Related Experiment Video
Updated: Apr 27, 2026
10:31
Isolation and Quantification of Zika Virus from Multiple Organs in a Mouse
Published on: August 15, 2019
7.1K
Antiviral perspectives for chikungunya virus
Deepti Parashar1, Sarah Cherian1
1National Institute of Virology, 20-A Dr. Ambedkar Road, Pune 411001, India.
Biomed Research International
|June 24, 2014
Summary
Chikungunya virus (CHIKV) causes debilitating joint pain and has re-emerged globally. Current treatments are limited to supportive care, with no licensed vaccines available for chikungunya infection.
Area of Science:
- Virology
- Infectious Diseases
- Public Health
Background:
- Chikungunya virus (CHIKV) is a mosquito-borne pathogen causing acute febrile illness and persistent joint pain in humans.
- CHIKV re-emerged in 2005-2006, leading to millions of cases and widespread outbreaks.
- The virus poses a significant threat for future expansion due to its re-emergence.
Purpose of the Study:
- To review current chikungunya treatment perspectives.
- To evaluate the effectiveness of existing and developing chikungunya treatment regimens.
- To discuss future directions for chikungunya therapy.
Main Methods:
- Literature review of chikungunya treatment strategies.
- Analysis of the effectiveness of various therapeutic approaches.
- Exploration of antiviral agents in development.
Main Results:
- No licensed vaccine against CHIKV infection is currently available for human use.
- Therapy for chikungunya infection remains primarily supportive.
- Antiviral agents are in various stages of testing and development.
Conclusions:
- There is an urgent need for effective chikungunya vaccines and antiviral therapies.
- Further research is crucial to develop novel treatment regimens for chikungunya.
- Exploring diverse treatment perspectives is essential to combat chikungunya outbreaks.
Related Concept Videos
01:30Inhibitors of Viral Protein Synthesis
57
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
57
01:28Viral Hepatitis I: Introduction
21
Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion...
21
01:27Cytomegalovirus Disease
96
Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
96
01:25Arboviral Encephalitis
53
Arboviral encephalitis refers to brain inflammation caused by arthropod-borne viruses, particularly those transmitted through mosquito vectors. Among these, West Nile virus (WNV), a member of the Flaviviridae family, is a significant public health concern. WNV is an enveloped, positive-sense, single-stranded RNA virus. Human infection typically begins when an infected mosquito introduces the virus into the dermis during feeding. The primary transmission cycle involves birds as amplifying hosts...
53